<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Gastroenterol</journal-id>
      <journal-id journal-id-type="iso-abbrev">BMC Gastroenterol</journal-id>
      <journal-title-group>
        <journal-title>BMC Gastroenterology</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1471-230X</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">27729029</article-id>
      <article-id pub-id-type="pmc">5059938</article-id>
      <article-id pub-id-type="publisher-id">537</article-id>
      <article-id pub-id-type="doi">10.1186/s12876-016-0537-x</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Malignant transformation of a gastric hyperplastic polyp in a context of <italic>Helicobacter pylori</italic>-negative autoimmune gastritis: a case report</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Yamanaka</surname>
            <given-names>Kenichi</given-names>
          </name>
          <address>
            <phone>+81-48-6472111</phone>
            <email>yken211@omiya.jichi.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Miyatani</surname>
            <given-names>Hiroyuki</given-names>
          </name>
          <address>
            <email>miyatani@omiya.jichi.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yoshida</surname>
            <given-names>Yukio</given-names>
          </name>
          <address>
            <email>yoyukio@omiya.jichi.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ishii</surname>
            <given-names>Takehiro</given-names>
          </name>
          <address>
            <email>take3546@jichi.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Asabe</surname>
            <given-names>Shinichi</given-names>
          </name>
          <address>
            <email>sasabe@jichi.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Takada</surname>
            <given-names>Osamu</given-names>
          </name>
          <address>
            <email>takata@omiya.jichi.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Nokubi</surname>
            <given-names>Mitsuhiro</given-names>
          </name>
          <address>
            <email>nokubi@jichi.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mashima</surname>
            <given-names>Hirosato</given-names>
          </name>
          <address>
            <email>hmashima1-tky@umin.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <aff id="Aff1"><label>1</label>Department of Gastroenterology, Jichi Medical University, Saitama Medical Center, Saitama, 330-8503 Japan </aff>
        <aff id="Aff2"><label>2</label>Department of Surgery, Jichi Medical University, Saitama Medical Center, Saitama, 330-8503 Japan </aff>
        <aff id="Aff3"><label>3</label>Department of Pathology, Jichi Medical University, Saitama Medical Center, Saitama, 330-8503 Japan </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>12</day>
        <month>10</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>12</day>
        <month>10</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2016</year>
      </pub-date>
      <volume>16</volume>
      <elocation-id>130</elocation-id>
      <history>
        <date date-type="received">
          <day>6</day>
          <month>4</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>29</day>
          <month>9</month>
          <year>2016</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Author(s). 2016</copyright-statement>
        <license license-type="OpenAccess">
          <license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <sec>
          <title>Background</title>
          <p>Gastric foveolar hyperplastic polyps (GFHPs) are common findings in clinical practice. GFHPs commonly arise in a background of chronic atrophic gastritis, including autoimmune gastritis (type A gastritis), and have a potential risk of malignant transformation.</p>
        </sec>
        <sec>
          <title>Case presentation</title>
          <p>In 2005, a 55-year-old Japanese woman underwent upper endoscopy at another hospital and was found to have a pedunculated polyp (10&#xA0;mm in diameter) on the greater curvature of the lower gastric body. On biopsy, the polyp was diagnosed as a GFHP. Nine years later, the polyp had grown to 20&#xA0;mm in diameter, and the biopsy specimen taken at this time showed tubular adenocarcinoma. On admission to our hospital, the serum <italic>Helicobacter Pylori</italic> (<italic>H. pylori)</italic> immunoglobulin G antibody and stool <italic>H. pylori</italic> antigen were both negative. Anti-gastric parietal cell antibody was positive, as was the anti-intrinsic factor antibody, and the fasting serum gastrin level was markedly increased. In 2014, en bloc resection of the pedunculated polyp was performed by endoscopic submucosal dissection. The final histological diagnosis was adenocarcinoma of the stomach with submucosal and lymphatic invasion. Subsequently, additional radical distal gastrectomy was performed. At the latest follow-up (12&#xA0;months postoperatively), no recurrence was noted.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>We here reported a rare case of malignant transformation of GFHP arising in a context of type A gastritis. To our knowledge, there are no previous reports on malignant transformation of GFHP with submucosal and lymphatic invasion arising in a background of type A gastritis in the English literature. Further, there is currently no effective treatment other than endoscopic or surgical treatment for such cases. Given the potential risk of malignant transformation due to hypergastrinemia, we consider that endoscopic treatment should be considered as a first-line therapy when a malignant growth is suspected.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Gastric hyperplastic foveolar polyp</kwd>
        <kwd>Autoimmune gastritis</kwd>
        <kwd>
          <italic>Helicobacter pylori</italic>
        </kwd>
        <kwd>Gastric carcinoma</kwd>
        <kwd>Case report</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; The Author(s) 2016</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1" sec-type="introduction">
      <title>Background</title>
      <p>Gastric foveolar hyperplastic polyps (GFHPs) are common findings in clinical practice. They do not regress or disappear spontaneously and are associated with a risk of malignant transformation in 0.6&#x2013;4.5&#xA0;% of cases [<xref ref-type="bibr" rid="CR1">1</xref>&#x2013;<xref ref-type="bibr" rid="CR5">5</xref>]. GFHPs commonly arise in a background of chronic atrophic gastritis, including both type B gastritis, associated with <italic>Helicobacter Pylori</italic> (<italic>H. pylori</italic>) infection, as well as type A gastritis (autoimmune gastritis) [<xref ref-type="bibr" rid="CR6">6</xref>]. In Japan, type B gastritis accounts for&#x2009;&gt;&#x2009;76&#xA0;% of all gastritis cases [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>]. A previous study reported that eradication of <italic>H. pylori</italic> led to regression and disappearance of gastric hyperplastic polyps in approximately 70&#xA0;% of patients [<xref ref-type="bibr" rid="CR9">9</xref>]. In this context, <italic>H. pylori</italic> eradication therapy is recommended in Japan. However, <italic>H. pylori</italic> eradication therapy is not effective for all cases, particular for GFHPs arising in a background of autoimmune gastritis (type A gastritis). With the increased prevalence and effectiveness of <italic>H. pylori</italic> eradication therapy, the clinical impact of autoimmune gastritis, and thereby also of GFHPs, is rising. There is currently no effective treatment other than endoscopic or surgical treatment for GFHPs arising in a background of <italic>H. pylori</italic>-negative type A gastritis. Therefore, endoscopic treatment is recommended as the first-line therapy when a malignant growth is suspected.</p>
    </sec>
    <sec id="Sec2">
      <title>Case presentation</title>
      <p>In November 2005, a 55-year-old Japanese woman underwent upper endoscopy at another hospital and was found to have a pedunculated polyp, measuring 10&#xA0;mm in diameter, on the greater curvature of the lower gastric body (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1a</xref>). On biopsy, it was diagnosed as a GFHP. At the moment of the first diagnosis, there was only an endoscopic report and the endoscopic appearance could be compatible with an atrophic mucosa. In January 2013, upper endoscopy was repeated, which revealed that the polyp had grown to 12&#xA0;mm in diameter with a slightly rounded head (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1b</xref>). Biopsy was not performed at the time.<fig id="Fig1"><label>Fig. 1</label><caption><p>Endoscopy findings. <bold>a</bold>. In 2005, a pedunculated polyp measuring approximately 10&#xA0;mm in diameter was observed on the greater curvature of the lower gastric body. The surface of the polyp was slightly reddish. On biopsy, the lesion was diagnosed as a hyperplastic foveolar polyp. <bold>b</bold>. In 2013, the pedunculated polyp on the greater curvature of the lower gastric body had grown to 12&#xA0;mm in diameter. The head of the polyp was more rounded compared to the image taken in 2005. <bold>c</bold>. In 2014, the pedunculated polyp on the greater curvature of the lower gastric body had grown to 20&#xA0;mm in diameter. The head of the polyp was slightly reddish, more rounded, and tense</p></caption><graphic xlink:href="12876_2016_537_Fig1_HTML" id="MO1"/></fig>
</p>
      <p>In June 2014, the patient underwent positron emission tomography-computed tomography to evaluate the treatment effect on her right breast cancer, for which she had undergone surgery and received chemotherapy and radiation therapy at the age of 53&#xA0;years. There was an abnormal accumulation in the lower gastric body (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>). Subsequent upper endoscopy showed that the polyp had grown to 20&#xA0;mm in diameter, and the surface of the head was slightly reddish and tense (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1c</xref>). The biopsy specimen obtained from the head of the polyp was histologically diagnosed as tubular adenocarcinoma and was determined to be unrelated to the breast cancer. It was suggested that the polyp became malignant during the nine years of follow-up, and the patient was referred to our institution for further evaluation and treatment.<fig id="Fig2"><label>Fig. 2</label><caption><p>Positron emission tomography-computed tomography findings. A well-circumscribed mass was observed in the lower gastric body, with a maximum standardized uptake value of 2.7</p></caption><graphic xlink:href="12876_2016_537_Fig2_HTML" id="MO2"/></fig>
</p>
      <sec id="Sec3">
        <title>Physical examination</title>
        <p>On physical examination, scars from the right breast mastectomy with bilateral axillary lymph node dissection were noted. No other remarkable findings were observed.</p>
      </sec>
      <sec id="Sec4">
        <title>Laboratory data (Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>)</title>
        <p>
<table-wrap id="Tab1"><label>Table 1</label><caption><p>Laboratory data</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Hematological analysis</th><th>Value</th><th>Unit</th><th>Blood chemistry</th><th>Value</th><th>Unit</th></tr></thead><tbody><tr><td>White blood cell count</td><td>4800</td><td>/&#x3BC;l</td><td>TP</td><td>7.3</td><td>g/dl</td></tr><tr><td>Hemoglobin</td><td>11.9</td><td>g/dl</td><td>Alb</td><td>4.4</td><td>g/dl</td></tr><tr><td>Hematocrit</td><td>37.8</td><td>%</td><td>T-bil</td><td>0.81</td><td>mg/dl</td></tr><tr><td>Platelets</td><td>19.5&#x2009;&#xD7;&#x2009;10<sup>4</sup>
</td><td>/&#x3BC;l</td><td>D-bil</td><td>0.24</td><td>mg/dl</td></tr><tr><td/><td/><td/><td>AST</td><td>34</td><td>U/L</td></tr><tr><td>Tumor markers</td><td/><td/><td>ALT</td><td>25</td><td>U/L</td></tr><tr><td>Carcinoembryonic antigen</td><td>1.3</td><td>ng/ml</td><td>LDH</td><td>197</td><td>U/L</td></tr><tr><td>Cancer antigen-15-3</td><td>17.1</td><td>U/ml</td><td>&#x3B3;-GTP</td><td>16</td><td>IU/l</td></tr><tr><td/><td/><td/><td>BUN</td><td>11</td><td>mg/dl</td></tr><tr><td>Anti&#x2010;parietal cell antibody</td><td>80</td><td>fold</td><td>Cre</td><td>0.55</td><td>mg/dl</td></tr><tr><td>Anti-intrinsic factor antibody</td><td>+</td><td/><td>Gastrin</td><td>&gt;3000</td><td>pg/dl</td></tr><tr><td>Pepsinogen I</td><td>7.6</td><td>ng/ml</td><td>Vit B12</td><td>208</td><td>pg/ml</td></tr><tr><td>Pepsinogen II</td><td>16.3</td><td>ng/ml</td><td/><td/><td/></tr><tr><td>Pepsinogen I/II/ ratio</td><td>&lt;0.5</td><td>ng/ml</td><td/><td/><td/></tr></tbody></table><table-wrap-foot><p>
<italic>Abbreviations</italic>: <italic>TP</italic> total protein, <italic>Alb</italic> albumin, <italic>T-bil</italic> total bilirubin, <italic>d-bil</italic> direct bilirubin, <italic>AST</italic> aspartate aminotransferase, <italic>ALT</italic> alanine aminotransferase, <italic>LDH</italic> lactate dehydrogenase, <italic>&#x3B3;-GTP</italic> gamma-glutamyl transpeptidase, <italic>BUN</italic> blood urea nitrogen, <italic>Cre</italic> creatinine, <italic>Vit</italic> vitamin</p></table-wrap-foot></table-wrap>
</p>
        <p>No abnormalities were found in the blood counts or liver and renal function tests. The serum <italic>H. pylori</italic> immunoglobulin G antibody and stool <italic>H. pylori</italic> antigen were both negative. The anti-gastric parietal cell antibody was positive (80-fold increase), as was the anti-intrinsic factor antibody. The fasting serum gastrin level was markedly increased at&#x2009;&gt;&#x2009;3000&#xA0;pg/ml (normal range, &lt; 200&#xA0;pg/ml). The serum pepsinogenI level and pepsinogen I/II ratio were both low (Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>).</p>
      </sec>
      <sec id="Sec5">
        <title>Medication</title>
        <p>The patient was not taking any medication at the time.</p>
      </sec>
      <sec id="Sec6">
        <title>Positron emission tomography-computed tomography (July 2014) (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>)</title>
        <p>A well-circumscribed mass with a maximum standardized uptake value of 2.7 was observed in the lower gastric body. There were no findings suggesting the presence of gastrinoma.</p>
      </sec>
      <sec id="Sec7">
        <title>Clinical course</title>
        <p>In August 2014, en bloc resection of the pedunculated polyp, measuring 20&#xA0;mm in diameter, on the greater curvature of the lower gastric body was performed by endoscopic submucosal dissection (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>).<fig id="Fig3"><label>Fig. 3</label><caption><p>Endoscopic submucosal dissection. En bloc endoscopic submucosal dissection was performed for the pedunculated polyp, measuring 20&#xA0;mm in diameter, on the greater curvature of the lower gastric body</p></caption><graphic xlink:href="12876_2016_537_Fig3_HTML" id="MO3"/></fig>
</p>
        <p>Histopathological examination showed tumor lesions, which had well-defined borders with hyperplastic glands (Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4a</xref>, <xref rid="Fig4" ref-type="fig">b</xref>). The tumor lesions were strongly positive for p53 and Ki-67, while the hyperplastic lesions were not (Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4c</xref>). Submucosal invasion was observed in the stalk, with an invasion depth of 300&#xA0;&#x3BC;m (Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4d</xref>). In D2-40-positive and cluster of differentiation 34-negative lymph ducts, cells with acidophilic cytoplasm and large nuclei were observed. The cells were positive for keratin, indicating lymphovascular invasion (Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4e</xref>). As a result the final histological diagnosis was adenocarcinoma of the stomach, tubular adenocarcinoma&#x2009;&gt;&#x2009;papillary adenocarcinoma, size of resected lesion 20&#xA0;mm in size, submucosal invasion of 0.3&#xA0;mm, venous invasion (-), lymphatic invasion (+).<fig id="Fig4"><label>Fig. 4</label><caption><p>Histological findings. <bold>a</bold>. Hematoxylin and eosin (HE) staining. <bold>b</bold>. High magnification image of the boxed area. <bold>c</bold>. HE, p53, and Ki-67 stainings of the border between the hyperplastic glands and the tumor glands. The tumor lesions were strongly positive for p53 and Ki-67. <bold>d</bold>. Submucosal invasion in the stalk, with an invasion depth of 300&#xA0;&#x3BC;m (MM, muscularis mucosae; SM, submucosal layer). <bold>e</bold>. HE, cluster of differentiation 34 (CD34), D2-40, and keratin staining. In CD34-negative and D2-40-positive lymph ducts, keratin-positive cells with acidophilic cytoplasm and large nuclei were observed, indicating lymphatic invasion (<italic>arrows</italic>)</p></caption><graphic xlink:href="12876_2016_537_Fig4_HTML" id="MO4"/></fig>
</p>
        <p>Consequently, additional radical distal gastrectomy was performed. Examination of the surgical specimens showed a scar resulting from the endoscopic submucosal dissection on the anterior wall of the gastric body. There were no residual tumor cells or lymph node metastasis. Examination of the background mucosa showed that the proper gastric glands in the pyloric region were preserved, while those in the mucosa of the gastric body were atrophic and showed intestinal metaplasia and pseudo-pyloric metaplasia (Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5</xref>). In the OLGA staging system, the corpus and the antrum were scored as 2 and 0, respectively, indicating stageII gastritis at the time of surgery [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR11">11</xref>]. Chromogranin A staining revealed enterochromaffin-like cell hyperplasia (linear hyperplasia and micronodular hyperplasia) (Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5b</xref>, arrows indicate micronodular hyperplasia). <italic>H. pylori</italic> infection was negative (Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5</xref>).<fig id="Fig5"><label>Fig. 5</label><caption><p>Examination of the background mucosa. <bold>a</bold>. The proper gastric glands in the pyloric region were preserved. There was no atrophic change. <bold>b</bold>. The proper gastric glands in the gastric body. The mucosa was atrophic and showed intestinal metaplasia and pseudo-pyloric metaplasia. Muc6 is a gastric pyloric gland- type secretory mucin. Enterochromaffin-like cell hyperplasia (linear hyperplasia and micro-nodular hyperplasia (<italic>arrows</italic>)) was revealed by chromogranin A staining</p></caption><graphic xlink:href="12876_2016_537_Fig5_HTML" id="MO5"/></fig>
</p>
      </sec>
    </sec>
    <sec id="Sec8">
      <title>Conclusions</title>
      <p>The classification of chronic gastritis into types A and B was proposed by Strickland et al. [<xref ref-type="bibr" rid="CR12">12</xref>]. However, currently, there are no established diagnostic criteria for the diagnosis of type A gastritis. Traditionally, type A gastritis has been diagnosed based on the anti-gastric parietal and anti-intrinsic factor antibody findings, presence of corpus-predominant atrophic gastritis, and serum gastrin levels, with Ban et al. stating that asymptomatic type A gastritis could be diagnosed by anti-gastric parietal antibody [<xref ref-type="bibr" rid="CR13">13</xref>]. The prevalence of autoimmune gastritis is unclear [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR14">14</xref>]. In the early stage, the diagnosis of type A gastritis is difficult even with a biopsy, since the symptoms of anemia due to malabsorption of vitamin B12 and iron usually develop at a later stage. In the present case, we considered that the patient was not infected with <italic>H. pylori</italic>, because her serum <italic>H. pylori</italic> immunoglobulin G antibody, stool <italic>H. pylori</italic> antigen, and histological examination were all negative. On the other hand, the patient was positive for anti-gastric parietal cell and anti-intrinsic factor antibodies, and had a markedly elevated level of serum gastrin and reduced pepsinogenI level and pepsinogenI/II ratio. Moreover, the patient had corpus-predominant atrophic gastritis, OLGA stageII, and enterochromaffin-like cell hyperplasia. Taken together, these findings led to the diagnosis of type A chronic atrophic gastritis. Although we did not have the sufficient histological data from the first endoscopy performed in 2005, mild corpus atrophy was detected at that time. Rugge et al. reported that in 116 patients with autoimmune gastritis, 87 cases (75.0&#xA0;%) remained and 25 cases (21.6&#xA0;%) progressed to a higher OLGA gastritis stage during a mean follow-up period of 54&#xA0;months (range, 24&#x2013;108 months) [<xref ref-type="bibr" rid="CR11">11</xref>]. Considering the gastritis stage in 2014, the present case can thus be speculated to have been at stageI orII in 2005. Type A gastritis is characterized by the presence of hypergastrinemia associated with reduced gastric acid secretion. Gastrin is a peptide hormone synthesized and released mainly from G cells in the gastric antrum, which plays a role in the regulation of gastric acid secretion and gastrointestinal motility [<xref ref-type="bibr" rid="CR15">15</xref>]. Furthermore, it is known to exert trophic actions on digestive cells [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR17">17</xref>]. In the present patient, it was suggested that the GFHP had grown during the nine-year follow-up period, owing to her hypergastrinemia; her serum gastrin level was&#x2009;&gt;&#x2009;3000&#xA0;pg/ml before undergoing distal gastrectomy, but decreased to 74&#xA0;pg/ml 48&#xA0;h after the surgery.</p>
      <p>The process of cancer development is considered to be a multistage process (hyperplasia &#x2794; dysplasia &#x2794; carcinoma); that is, as the polyp grows and becomes more dysplastic, the risk of cancer increases [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR19">19</xref>]. The most important risk factors of malignant transformation in chronic atrophic gastritis include age over 50&#xA0;years, severe atrophy, and the presence of intestinal metaplasia extension [<xref ref-type="bibr" rid="CR20">20</xref>]. The present patient fit the first and third risk factors. Rugge et al. reported that the risk of cancer was restricted to case of high-risk gastritis stage (OLGA stages III-IV) and that it was associated mainly with concomitant <italic>H. pylori</italic> infection [<xref ref-type="bibr" rid="CR11">11</xref>]. However, malignant transformation in type A gastritis associated with hypergastrinemia might be induced at an earlier gastritis stage. Several genetic alterations have been revealed in hyperplastic polyps, including abnormal expression of tumor suppressor p53, K-ras mutations, and microsatellite instability [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR21">21</xref>]. Shibahara et al. conducted a study of gastric hyperplastic polyps and reported that increased expression of p53 was observed in dysplastic and carcinoma cells but not in the normal or hyperplastic cells, and that the expression of Ki67 was higher in the carcinoma and dysplastic cells than in the hyperplastic cells. They suggested that examinations of p53 and Ki67 were useful markers of malignant transformation of gastric hyperplastic polyps [<xref ref-type="bibr" rid="CR22">22</xref>]. Yao et al. and Zea-Iriarte et al. also suggested that p53 plays an important role in the malignant transformation of gastric hyperplastic polyps [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR23">23</xref>]. In the present case, the expression of p53 was strongly positive in the carcinoma cells and Ki67 was positive in approximately 50&#xA0;% of the carcinoma cells, while these stainings were much decreased in the non-transformed cells (Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4b</xref>).</p>
      <p>The reported incidence of malignant transformation of GFHP ranges from 0.6 to 4.5&#xA0;% [<xref ref-type="bibr" rid="CR1">1</xref>&#x2013;<xref ref-type="bibr" rid="CR5">5</xref>], and Fujino et al. reported that the mean diameter of GFHPs with malignant transformation was as large as 23.4&#x2009;&#xB1;&#x2009;10.2&#xA0;mm [<xref ref-type="bibr" rid="CR24">24</xref>]. Regarding the histological type, most previously reported cases were differentiated adenocarcinomas, while a few were poorly-differentiated adenocarcinomas or signet ring cell carcinomas [<xref ref-type="bibr" rid="CR25">25</xref>&#x2013;<xref ref-type="bibr" rid="CR28">28</xref>]. The GFHP in the present patient was 20&#xA0;mm in diameter and histologically diagnosed as differentiated adenocarcinoma (Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4</xref>).</p>
      <p>The diagnostic criteria of malignant GFHP proposed by Nakamura et al. in 1985 are as follows [<xref ref-type="bibr" rid="CR29">29</xref>]: 1) coexistence of benign and malignant parts in the same polyp; 2) existence of sufficient evidence that the benign area has previously been a benign polyp; and 3) existence of sufficient cellular and structural atypia in the malignant area to be diagnosed as cancer. The patient in the present study met these criteria and was therefore diagnosed with malignant transformation of GFHP over nine years. GFHPs with carcinoma have been reported to have the following macroscopic characteristics: pedunculated form, larger size (&gt;20&#xA0;mm), reddish color, irregular or nodular surface, white-coated, and bleeding tendency [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR31">31</xref>]. Our patient displayed four of these macroscopic features, including pedunculated form, a diameter&#x2009;&gt;&#x2009;20&#xA0;mm, growth tendency, and a white-coated lesion.</p>
      <p>It has been reported that magnifying endoscopy with narrow band imaging is useful for the diagnosis of cancer [<xref ref-type="bibr" rid="CR32">32</xref>&#x2013;<xref ref-type="bibr" rid="CR34">34</xref>]; however, it is not sufficiently useful for diagnosing malignant transformation of gastric hyperplastic polyps [<xref ref-type="bibr" rid="CR23">23</xref>]. Ahn et al. reported that GFHPs measuring 10&#xA0;mm or larger in diameter should be endoscopically resected [<xref ref-type="bibr" rid="CR35">35</xref>], whereas Tanabe et al. reported the disappearance of a 20&#xA0;mm hyperplastic polyp with malignant transformation after <italic>H. pylori</italic> eradication therapy [<xref ref-type="bibr" rid="CR36">36</xref>]. The lesion in the present patient was diagnosed as tubular adenocarcinoma on biopsy. Endoscopic estimation of the invasion depth of the carcinoma was difficult; hence, endoscopic submucosal dissection, a minimally invasive procedure, was performed. The results showed a submucosal invasion depth of 0.3&#xA0;mm and lymph duct invasion. Subsequently, we performed additional distal gastrectomy and lymph node dissection. There was no distant metastasis, and we considered that complete removal of the tumor was achieved. At the time of this report, the patient has been followed-up for 12&#xA0;months after surgery with no recurrence.</p>
      <p>To our knowledge, there are only a few previous cases, limited to Japan, of malignant GFHP with submucosal invasion requiring surgical treatment [<xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR38">38</xref>], and there are no previous reports on malignant transformation of GFHP with submucosal invasion and lymphatic invasion arising in a background of type A gastritis in the English literature. Thus, the present case is considered very rare and to provide valuable information. Importantly, there is currently no effective treatment other than endoscopic or surgical treatment for GFHPs, secondary to type A gastritis. Moreover, as this type of polyp has a potential risk of malignant transformation due to hypergastrinemia, endoscopic or surgical treatment should be considered when malignant transformation is suspected.</p>
    </sec>
  </body>
  <back>
    <glossary>
      <title>Abbreviation</title>
      <def-list>
        <def-item>
          <term>GFHP</term>
          <def>
            <p>Gastric foveolar hyperplastic polyp</p>
          </def>
        </def-item>
      </def-list>
    </glossary>
    <ack>
      <title>Acknowledgements</title>
      <p>None.</p>
      <sec id="FPar1">
        <title>Funding</title>
        <p>None.</p>
      </sec>
      <sec id="FPar2">
        <title>Availability of data and materials</title>
        <p>Not applicable.</p>
      </sec>
      <sec id="FPar3">
        <title>Authors&#x2019; contributions</title>
        <p>YK, MH, YY, IT, TO, NM, and MH performed the research; YK designed the research, analyzed the data, and wrote the paper; AS revised the manuscript critically. All authors read and approved the final manuscript.</p>
      </sec>
      <sec id="FPar4">
        <title>Competing interests</title>
        <p>The authors declare that they have no competing interests.</p>
      </sec>
      <sec id="FPar5">
        <title>Consent for publication</title>
        <p>Written consent was obtained from the patient.</p>
      </sec>
      <sec id="FPar6">
        <title>Ethics approval and consent to participate</title>
        <p>Written consent was obtained from the patient. As this is a case report, approval from the Etiological Study Ethical Review Board of Saitama Medical Center, Jichi Medical University was not needed.</p>
      </sec>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Abraham</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Singh</surname>
              <given-names>VK</given-names>
            </name>
            <name>
              <surname>Yardley</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>TT</given-names>
            </name>
          </person-group>
          <article-title>Hyperplastic polyps of the stomach: associations with histologic patterns of gastritis and gastric atrophy</article-title>
          <source>Am J Surg Pathol</source>
          <year>2001</year>
          <volume>25</volume>
          <fpage>500</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="doi">10.1097/00000478-200104000-00010</pub-id>
          <pub-id pub-id-type="pmid">11257625</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Daibo</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Itabashi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hirota</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Malignant transformation of gastric hyperplastic polyps</article-title>
          <source>Am J Gastroenterol</source>
          <year>1987</year>
          <volume>82</volume>
          <fpage>1016</fpage>
          <lpage>25</lpage>
          <pub-id pub-id-type="pmid">3661508</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Orlowska</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Jarosz</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Pachlewski</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Butruk</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Malignant transformation of benign epithelial gastric polyps</article-title>
          <source>Am J Gastroenterol</source>
          <year>1995</year>
          <volume>90</volume>
          <fpage>2152</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">8540506</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hattori</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Morphological range of hyperplastic polyps and carcinomas arising in hyperplastic polyps of the stomach</article-title>
          <source>J Clin Pathol</source>
          <year>1985</year>
          <volume>38</volume>
          <fpage>622</fpage>
          <lpage>30</lpage>
          <pub-id pub-id-type="doi">10.1136/jcp.38.6.622</pub-id>
          <pub-id pub-id-type="pmid">4008664</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Terada</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Malignant transformation of foveolar hyperplastic polyp of the stomach: a histopathological study</article-title>
          <source>Med Oncol</source>
          <year>2011</year>
          <volume>28</volume>
          <fpage>941</fpage>
          <lpage>4</lpage>
          <pub-id pub-id-type="doi">10.1007/s12032-010-9556-6</pub-id>
          <pub-id pub-id-type="pmid">20458557</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Coati</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Fassan</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Farinati</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Graham</surname>
              <given-names>DY</given-names>
            </name>
            <name>
              <surname>Genta</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Rugge</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Autoimmune gastritis: pathologist&#x2019;s viewpoint</article-title>
          <source>World J Gastroenterol</source>
          <year>2015</year>
          <volume>21</volume>
          <fpage>12179</fpage>
          <lpage>89</lpage>
          <pub-id pub-id-type="doi">10.3748/wjg.v21.i42.12179</pub-id>
          <pub-id pub-id-type="pmid">26576102</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ljubici&#x107;</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Bani&#x107;</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kujundzi&#x107;</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Anti&#x107;</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Vrkljan</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kovacevi&#x107;</surname>
              <given-names>I</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The effect of eradicating Helicobacter pylori infection on the course of adenomatous and hyperplastic gastric polyps</article-title>
          <source>Eur J Gastroenterol Hepatol</source>
          <year>1999</year>
          <volume>11</volume>
          <fpage>727</fpage>
          <lpage>30</lpage>
          <pub-id pub-id-type="doi">10.1097/00042737-199907000-00008</pub-id>
          <pub-id pub-id-type="pmid">10445791</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bonilla Palacios</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Miyazaki</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Kanayuma</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Yasunaga</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Matsuzawa</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Serum gastrin, pepsinogens, parietal cell and Helicobacter pylori antibodies in patients with gastric polyps</article-title>
          <source>Acta Gastroenterol Latinoam</source>
          <year>1994</year>
          <volume>24</volume>
          <fpage>77</fpage>
          <lpage>82</lpage>
          <pub-id pub-id-type="pmid">7817697</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Okusa</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Takashimizu</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Fujiki</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Suzuki</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Shimoi</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Horiuchi</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Disappearance of hyperplastic polyps in the stomach after eradication of Helicobacter pylori. A randomised, clinical trial</article-title>
          <source>Ann Intern Med</source>
          <year>1998</year>
          <volume>129</volume>
          <fpage>712</fpage>
          <lpage>5</lpage>
          <pub-id pub-id-type="doi">10.7326/0003-4819-129-9-199811010-00006</pub-id>
          <pub-id pub-id-type="pmid">9841603</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rugge</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Correa</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Di Mario</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>El-Omar</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Fiocca</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Geoboes</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>OLGA staging for gastritis: a tutorial</article-title>
          <source>Dig Liver Dis</source>
          <year>2008</year>
          <volume>40</volume>
          <fpage>650</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="doi">10.1016/j.dld.2008.02.030</pub-id>
          <pub-id pub-id-type="pmid">18424244</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rugge</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Fassan</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Pizzi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Zorzetto</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Maddalo</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Realdon</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Autoimmune gastritis: histology phenotype and OLGA staging</article-title>
          <source>Aliment Pharmacol Ther</source>
          <year>2012</year>
          <volume>35</volume>
          <fpage>1460</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1365-2036.2012.05101.x</pub-id>
          <pub-id pub-id-type="pmid">22519568</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Strickland</surname>
              <given-names>RG</given-names>
            </name>
            <name>
              <surname>Mackay</surname>
              <given-names>IR</given-names>
            </name>
          </person-group>
          <article-title>A reappraisal of nature and significance of chronic atrophic gastritis</article-title>
          <source>Am J Dig Dis</source>
          <year>1973</year>
          <volume>18</volume>
          <fpage>426</fpage>
          <lpage>40</lpage>
          <pub-id pub-id-type="doi">10.1007/BF01071995</pub-id>
          <pub-id pub-id-type="pmid">4573514</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Toh</surname>
              <given-names>BH</given-names>
            </name>
          </person-group>
          <article-title>Diagnosis and classification of autoimmune gastritis</article-title>
          <source>Autoimmun Rev</source>
          <year>2014</year>
          <volume>13</volume>
          <fpage>459</fpage>
          <lpage>62</lpage>
          <pub-id pub-id-type="doi">10.1016/j.autrev.2014.01.048</pub-id>
          <pub-id pub-id-type="pmid">24424193</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Toh</surname>
              <given-names>BH</given-names>
            </name>
            <name>
              <surname>Chan</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Kyaw</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Alderuccio</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Cutting edge issues in autoimmune gastritis</article-title>
          <source>Clin Rev Allergy Immunol</source>
          <year>2012</year>
          <volume>42</volume>
          <fpage>269</fpage>
          <lpage>78</lpage>
          <pub-id pub-id-type="doi">10.1007/s12016-010-8218-y</pub-id>
          <pub-id pub-id-type="pmid">21174235</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dockray</surname>
              <given-names>GJ</given-names>
            </name>
            <name>
              <surname>Varro</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Dimaline</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>The gastrins: their production and biological activities</article-title>
          <source>Annu Rev Physiol</source>
          <year>2001</year>
          <volume>63</volume>
          <fpage>119</fpage>
          <lpage>39</lpage>
          <pub-id pub-id-type="doi">10.1146/annurev.physiol.63.1.119</pub-id>
          <pub-id pub-id-type="pmid">11181951</pub-id>
        </element-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Smith</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Watson</surname>
              <given-names>SA</given-names>
            </name>
          </person-group>
          <article-title>Review article: gastrin and colorectal cancer</article-title>
          <source>Aliment Pharmacol Ther</source>
          <year>2000</year>
          <volume>14</volume>
          <fpage>1231</fpage>
          <lpage>47</lpage>
          <pub-id pub-id-type="doi">10.1046/j.1365-2036.2000.00842.x</pub-id>
          <pub-id pub-id-type="pmid">11012467</pub-id>
        </element-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rozengurt</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Walsh</surname>
              <given-names>JH</given-names>
            </name>
          </person-group>
          <article-title>Gastrin, CCK, signaling, and cancer</article-title>
          <source>Annu Rev Physiol</source>
          <year>2001</year>
          <volume>63</volume>
          <fpage>49</fpage>
          <lpage>76</lpage>
          <pub-id pub-id-type="doi">10.1146/annurev.physiol.63.1.49</pub-id>
          <pub-id pub-id-type="pmid">11181948</pub-id>
        </element-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dijkhuizen</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Entius</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Clement</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Polak</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Van den Berg</surname>
              <given-names>FM</given-names>
            </name>
            <name>
              <surname>Craanen</surname>
              <given-names>ME</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Multiple hyperplastic polyps in the stomach: evidence for clonality and neoplastic potential</article-title>
          <source>Gastroenterology</source>
          <year>1997</year>
          <volume>112</volume>
          <fpage>561</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="doi">10.1053/gast.1997.v112.pm9024310</pub-id>
          <pub-id pub-id-type="pmid">9024310</pub-id>
        </element-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yao</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kajiwara</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kuroiwa</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Iwashita</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Oya</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kabashima</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Malignant transformation of gastric hyperplastic polyps: alteration of phenotypes, proliferative activity, and p53 expression</article-title>
          <source>Hum Pathol</source>
          <year>2002</year>
          <volume>33</volume>
          <fpage>1016</fpage>
          <lpage>22</lpage>
          <pub-id pub-id-type="doi">10.1053/hupa.2002.126874</pub-id>
          <pub-id pub-id-type="pmid">12395375</pub-id>
        </element-citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vannella</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Lahner</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Annibale</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Risk of gastric neoplasias in patients with chronic atrophic gastritis: a critical reappraisal</article-title>
          <source>World J Gastroenterol</source>
          <year>2012</year>
          <volume>18</volume>
          <fpage>1279</fpage>
          <lpage>85</lpage>
          <pub-id pub-id-type="doi">10.3748/wjg.v18.i12.1279</pub-id>
          <pub-id pub-id-type="pmid">22493541</pub-id>
        </element-citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nogueria</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Carneiro</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Seruca</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Cirnes</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Veiga</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Machado</surname>
              <given-names>JC</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Microsatellite instability in hyperplastic and adenomatous polyps of the stomach</article-title>
          <source>Cancer</source>
          <year>1999</year>
          <volume>86</volume>
          <fpage>1649</fpage>
          <lpage>56</lpage>
          <pub-id pub-id-type="doi">10.1002/(SICI)1097-0142(19991101)86:9&lt;1649::AID-CNCR5&gt;3.0.CO;2-N</pub-id>
          <pub-id pub-id-type="pmid">10547536</pub-id>
        </element-citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shibahara</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Haraguchi</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Sasaki</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Kiyonari</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Oishi</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Iwashita</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A case of gastric hyperplastic polyp with malignant transformation</article-title>
          <source>Hepatogastroenterology</source>
          <year>2005</year>
          <volume>52</volume>
          <fpage>319</fpage>
          <lpage>21</lpage>
          <pub-id pub-id-type="pmid">15783059</pub-id>
        </element-citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zea-Iriarte</surname>
              <given-names>WL</given-names>
            </name>
            <name>
              <surname>Sekine</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Itsuno</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Makiyama</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Naito</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Nakayama</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Carcinoma in gastric hyperplastic polyps. A phenotypic study</article-title>
          <source>Dig Dis Sci</source>
          <year>1996</year>
          <volume>41</volume>
          <fpage>377</fpage>
          <lpage>86</lpage>
          <pub-id pub-id-type="doi">10.1007/BF02093832</pub-id>
          <pub-id pub-id-type="pmid">8601386</pub-id>
        </element-citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fujino</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Yamamoto</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Morozumi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kawai</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Malignant transformation of gastric polyps</article-title>
          <source>Nihon Rinsho</source>
          <year>1991</year>
          <volume>49</volume>
          <fpage>155</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">1787566</pub-id>
        </element-citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zea-Iriarte</surname>
              <given-names>WL</given-names>
            </name>
            <name>
              <surname>Itsuno</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Makiyama</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Hara</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Haraguchi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ajioka</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Signet ring cell carcinoma in hyperplastic polyp</article-title>
          <source>Scand J Gastroenterol</source>
          <year>1995</year>
          <volume>30</volume>
          <fpage>604</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="doi">10.3109/00365529509089797</pub-id>
          <pub-id pub-id-type="pmid">7569771</pub-id>
        </element-citation>
      </ref>
      <ref id="CR26">
        <label>26.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fry</surname>
              <given-names>LC</given-names>
            </name>
            <name>
              <surname>Lazenby</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>DH</given-names>
            </name>
            <name>
              <surname>M&#xF6;nkem&#xFC;ller</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Signet-ring-cell adenocarcinoma arising from a hyperplastic polyp</article-title>
          <source>Gastrointest Endosc</source>
          <year>2005</year>
          <volume>61</volume>
          <fpage>493</fpage>
          <lpage>5</lpage>
          <pub-id pub-id-type="doi">10.1016/S0016-5107(04)02640-9</pub-id>
          <pub-id pub-id-type="pmid">15758936</pub-id>
        </element-citation>
      </ref>
      <ref id="CR27">
        <label>27.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gotoh</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Fujimoto</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Sakata</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Fujisaki</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Nakano</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Poorly differentiated adenocarcinoma in a gastric hyperplastic polyp</article-title>
          <source>South Med J</source>
          <year>1996</year>
          <volume>89</volume>
          <fpage>453</fpage>
          <lpage>4</lpage>
          <pub-id pub-id-type="doi">10.1097/00007611-199604000-00026</pub-id>
          <pub-id pub-id-type="pmid">8614897</pub-id>
        </element-citation>
      </ref>
      <ref id="CR28">
        <label>28.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hirasaki</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Suzuki</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kanzaki</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Fujita</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Matsumura</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Matsumoto</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Minute signet ring cell carcinoma occurring in gastric hyperplastic polyp</article-title>
          <source>World J Gastroenterol</source>
          <year>2007</year>
          <volume>13</volume>
          <fpage>5779</fpage>
          <lpage>80</lpage>
          <pub-id pub-id-type="doi">10.3748/wjg.v13.i43.5779</pub-id>
          <pub-id pub-id-type="pmid">17963309</pub-id>
        </element-citation>
      </ref>
      <ref id="CR29">
        <label>29.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nakamura</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Nakano</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Histological classification and malignant change in gastric polyps</article-title>
          <source>J Clin Pathol</source>
          <year>1985</year>
          <volume>38</volume>
          <fpage>754</fpage>
          <lpage>64</lpage>
          <pub-id pub-id-type="doi">10.1136/jcp.38.7.754</pub-id>
          <pub-id pub-id-type="pmid">4019798</pub-id>
        </element-citation>
      </ref>
      <ref id="CR30">
        <label>30.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mitsufuji</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Tsuchihashi</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Isetani</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Tokita</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Maruyama</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Hosokawa</surname>
              <given-names>Y</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A ten-year observation of malignant changes in a hyperplastic polyp of the stomach--a cellular kinetic study using bromodeoxyuridine (BrdU)</article-title>
          <source>Gan No Rinsho</source>
          <year>1990</year>
          <volume>36</volume>
          <fpage>1035</fpage>
          <lpage>41</lpage>
          <pub-id pub-id-type="pmid">2381049</pub-id>
        </element-citation>
      </ref>
      <ref id="CR31">
        <label>31.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yamaguchi</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Shiraishi</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Maeda</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kitamura</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Adenocarcinoma in hyperplastic polyp of the stomach</article-title>
          <source>Am J Gastroenterol</source>
          <year>1990</year>
          <volume>85</volume>
          <fpage>327</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">2309688</pub-id>
        </element-citation>
      </ref>
      <ref id="CR32">
        <label>32.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hirano</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Yoshida</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Yoshimura</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Fukuoka</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ohkubo</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Tachibana</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Poorly differentiated adenocarcinoma with signet-ring cell carcinoma in a hyperplastic polyp of the stomach: report of a case</article-title>
          <source>Surg Today</source>
          <year>2007</year>
          <volume>37</volume>
          <fpage>901</fpage>
          <lpage>4</lpage>
          <pub-id pub-id-type="doi">10.1007/s00595-007-3506-8</pub-id>
          <pub-id pub-id-type="pmid">17879044</pub-id>
        </element-citation>
      </ref>
      <ref id="CR33">
        <label>33.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yao</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Oishi</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Matsui</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Yao</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Iwashita</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Novel magnified endoscopic findings of microvascular architecture in intramucosal gastric cancer</article-title>
          <source>Gastrointest Endosc</source>
          <year>2002</year>
          <volume>56</volume>
          <fpage>279</fpage>
          <lpage>84</lpage>
          <pub-id pub-id-type="doi">10.1016/S0016-5107(02)70194-6</pub-id>
          <pub-id pub-id-type="pmid">12145613</pub-id>
        </element-citation>
      </ref>
      <ref id="CR34">
        <label>34.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yao</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Takaki</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Matsui</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Iwashita</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Anagnostopoulos</surname>
              <given-names>GK</given-names>
            </name>
            <name>
              <surname>Kaye</surname>
              <given-names>P</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Clinical application of magnification endoscopy and narrow-band imaging in the upper gastrointestinal tract: new imaging techniques for detecting and characterizing gastrointestinal neoplasia</article-title>
          <source>Gastrointest Endosc Clin N Am</source>
          <year>2008</year>
          <volume>18</volume>
          <fpage>415</fpage>
          <lpage>33</lpage>
          <pub-id pub-id-type="doi">10.1016/j.giec.2008.05.011</pub-id>
          <pub-id pub-id-type="pmid">18674694</pub-id>
        </element-citation>
      </ref>
      <ref id="CR35">
        <label>35.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ahn</surname>
              <given-names>JY</given-names>
            </name>
            <name>
              <surname>da Son</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Choi</surname>
              <given-names>KD</given-names>
            </name>
            <name>
              <surname>Roh</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Lim</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Choi</surname>
              <given-names>KS</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Neoplasms arising in large gastric hyperplastic polyps: endoscopic and pathologic features</article-title>
          <source>Gastrointest Endosc</source>
          <year>2014</year>
          <volume>80</volume>
          <fpage>1005</fpage>
          <lpage>13</lpage>
          <pub-id pub-id-type="doi">10.1016/j.gie.2014.04.020</pub-id>
          <pub-id pub-id-type="pmid">24929480</pub-id>
        </element-citation>
      </ref>
      <ref id="CR36">
        <label>36.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tanabe</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Hara</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Ohkubo</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Miyokawa</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Sano</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Disappearance of gastric adenocarcinoma in hyperplastic polyp after eradication of Helicobacter pylori</article-title>
          <source>Nihon Shokakibyo Gakkai Zasshi</source>
          <year>2005</year>
          <volume>102</volume>
          <fpage>559</fpage>
          <lpage>63</lpage>
          <pub-id pub-id-type="pmid">15920952</pub-id>
        </element-citation>
      </ref>
      <ref id="CR37">
        <label>37.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nimura</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kashiwagi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Mitsumori</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Arai</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Yonezawa</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Kaise</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The easy endoscopic polypectomy of gastric hyperplastic polyp should not be carried out</article-title>
          <source>Shokaki Geka</source>
          <year>2007</year>
          <volume>30</volume>
          <fpage>569</fpage>
          <lpage>79</lpage>
        </element-citation>
      </ref>
      <ref id="CR38">
        <label>38.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yamashita</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kaise</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Malignant transformation in a case of gastric hyperplastic polyp</article-title>
          <source>Shokaki Naishikyo</source>
          <year>2015</year>
          <volume>27</volume>
          <fpage>101</fpage>
          <lpage>5</lpage>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
